F. Stephen Hodi

Also affiliated with Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.6Author DataRank

Indexed papers

8in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 8 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

Nature Medicine(2020)10.1038/s41591-020-0844-1

Top 4%

5.6DataRank

Top 4%819 citations

Caroline B. M. Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro +45 more

Papers

Driven by 62 papers — median percentile 0. Top paper: “Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma”.

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

New England Journal of Medicine(2019)10.1056/nejmoa1910836

N/A

14.8DataRank · unranked

3741 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D. Lao +26 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

9.5DataRank · unranked

393 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors

Nature Medicine(2020)10.1038/s41591-020-0844-1

Top 4%

5.6DataRank

Top 4%819 citations

Caroline B. M. Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro +45 more

Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00658-6

N/A

4.8DataRank · unranked

234 citations

Anita Giobbie‐Hurder, Srinika Ranasinghe, Katrina Kao, Ana Lako, Junko Tsuji +32 more

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-Oncology(2021)10.1093/neuonc/noab094

N/A

4.0DataRank · unranked

126 citations

Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid +18 more

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010

N/A

3.9DataRank · unranked

100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1416

N/A

2.7DataRank · unranked

71 citations

David Liu, Diana Miao, Bart Lutterbach, Alexander L. DeVine, Chenyu Lin +19 more

A single-cell and single-nucleus RNA-seq toolbox for fresh and frozen human tumors

bioRxiv (Cold Spring Harbor Laboratory)(2019)10.1101/761429

N/A

2.5DataRank · unranked

68 citations

Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Indresh Singh +44 more

Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma

Cancer Cell(2023)10.1016/j.ccell.2023.03.010

N/A

2.2DataRank · unranked

82 citations

Meelad Amouzgar, Shannon M. Pfeiffer, Timothy R. Howes, Egmidio Medina, Michael J. Travers +14 more

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood(2020)10.1182/blood.2020006464

N/A

1.9DataRank · unranked

59 citations

Jason L. Weirather, Margaretha G.M. Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen +26 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2021)10.1016/j.ccell.2020.11.015

N/A

1.9DataRank · unranked

53 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo +31 more

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

New England Journal of Medicine(2018)10.1056/nejmoa1805453

N/A

1.1DataRank · unranked

1335 citations

Peter A. Forsyth, Alain Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos +17 more

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

Cell(2020)10.1016/j.cell.2020.06.001

N/A

0.927DataRank · unranked

481 citations

Shengbao Suo, Hannah L. Williams, Tatyana Sharova, Keri M. Sullivan, Michael P. Manos +11 more

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1963

N/A

0.889DataRank · unranked

374 citations

Randy F. Sweis, F. Stephen Hodi, Wells A. Messersmith, Robert H.I. Andtbacka, Matthew Ingham +11 more

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0812

N/A

0.848DataRank · unranked

284 citations

Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Ziyi Li +28 more

Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors

Cell(2021)10.1016/j.cell.2021.08.020

N/A

0.766DataRank · unranked

164 citations

Amanda M. Cruz, Grace E. Crossland, Giorgio Gaglia, Cecily C. Ritch, Sarah E. Blatt +23 more

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004310

N/A

0.762DataRank · unranked

19 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +9 more

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z

N/A

0.722DataRank · unranked

122 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Cancer Cell(2022)10.1016/j.ccell.2022.08.022

N/A

0.717DataRank · unranked

118 citations

Elio Adib, Sarah Abou Alaiwi, Talal El Zarif, Stefan Groha, Elie W. Akl +27 more

Mechanical checkpoint regulates monocyte differentiation in fibrotic niches

Nature Materials(2022)10.1038/s41563-022-01293-3

N/A

0.672DataRank · unranked

87 citations

Anna E. Marneth, Kwasi Adu‐Berchie, Joshua M. Grolman, Christina M. Tringides, Yutong Liu +10 more

Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0866

N/A

0.657DataRank · unranked

79 citations

Amin H. Nassar, Wanling Xie, Ziad Bakouny, Jacob E. Berchuck, David A. Braun +27 more

Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047

Journal of Clinical Oncology(2025)10.1200/jco.24.01124

N/A

0.633DataRank · unranked

67 citations

F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo A. Ascierto, Luis Matamala +14 more

Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

Journal of Translational Medicine(2022)10.1186/s12967-022-03450-3

N/A

0.614DataRank · unranked

12 citations

Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield +10 more

Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5023

N/A

0.599DataRank · unranked

12 citations

Opeyemi A. Jegede, Miriam Sant’Angelo, Sonia Moreno, David A. Braun, Megan Wind‐Rotolo +15 more

Outcomes after resumption of immune checkpoint inhibitor therapy after high‐grade immune‐mediated hepatitis

Cancer(2020)10.1002/cncr.33165

N/A

0.598DataRank · unranked

53 citations

Jordan Sack, Osama E. Rahma, F. Stephen Hodi, Stephen D. Zucker, Shilpa Grover +1 more

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Blood(2023)10.1182/blood.2022018246

N/A

0.593DataRank · unranked

51 citations

Yang Liu, Jacquelyn O. Wolff, Lin Yang, Len Taing, Aashna Jhaveri +32 more

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

npj Precision Oncology(2021)10.1038/s41698-021-00197-w

N/A

0.571DataRank · unranked

44 citations

Ashwin S. Kumar, Jessica M. Posada, Evisa Gjini, Kathleen L. Pfaff, Mikel Lipschitz +6 more

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood(2021)10.1182/blood.2021010867

N/A

0.564DataRank · unranked

42 citations

Yi Zhang, Alexandra Savell, Teddy Huang, Nicoletta Cieri, Emily M. Thrash +33 more

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003743

N/A

0.542DataRank · unranked

36 citations

Charlene Mantia, Lillian Werner, Ahmad A. Tarhini, James Larkin, F. Stephen Hodi +10 more

Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma

Cancer Cell(2025)10.1016/j.ccell.2025.01.009

N/A

0.524DataRank · unranked

32 citations

Mouadh Benamar, Jihye Park, Haley E. Sax, Giacomo Oliveira, Alice Bosma-Moody +10 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002535

N/A

0.520DataRank · unranked

31 citations

Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid +16 more

EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0171

N/A

0.500DataRank · unranked

27 citations

Dinesh Thapa, Anita Giobbie‐Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol +7 more

Hippo Signaling Pathway Regulates Cancer Cell–Intrinsic MHC-II Expression

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0227

N/A

0.470DataRank · unranked

22 citations

Shengqing Gu, Nofal Ouardaoui, Carly Tymm, Lin Yang, Cheryl J. Wong +9 more

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study

Clinical and Translational Science(2024)10.1111/cts.13854

N/A

0.360DataRank · unranked

10 citations

Debbie Robbrecht, Ryan Sullivan, Bernard Doger, Armando Santoro, Minal Barve +16 more

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0420

N/A

0.345DataRank · unranked

9 citations

Ju‐Whei Lee, Angela Wangari Walter, Rachel Rosen, Ilana F. Gareen, Sheetal Mehta Kircher +17 more

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-1027

N/A

0.292DataRank · unranked

6 citations

Osama E. Rahma, Kevin Tyan, Yvonne Li, Anita Giobbie‐Hurder, Benjamin L. Schlechter +18 more

Circulating cytokine associations with clinical outcomes in melanoma patients treated with combination nivolumab plus ipilimumab

OncoImmunology(2024)10.1080/2162402x.2024.2432723

N/A

0.292DataRank · unranked

6 citations

Giuseppe Tarantino, Mariano Severgnini, Joanna Bagińska, Anita Giobbie‐Hurder, Jason L. Weirather +14 more

A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade

Haematologica(2020)10.3324/haematol.2020.258426

N/A

0.269DataRank · unranked

5 citations

Adam S. Sperling, Christopher J. Gibson, Olga Pozdnyakova, Waihay J. Wong, Michael P. Manos +5 more

Granulocyte–Macrophage Colony-Stimulating Factor Influence on Soluble and Membrane-Bound ICOS in Combination with Immune Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0702

N/A

0.241DataRank · unranked

4 citations

Jingjing Li, Yue Zheng, Sandra J. Lee, Jun Zhou, Anita Giobbie‐Hurder +4 more

Stratified analysis identifies HIF-2 α as a therapeutic target for highly immune-infiltrated melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.29.620300

N/A

0.231DataRank · unranked

3 citations

Kelly P. Burke, Ryan Porter, Lynn Meiger, Peter Fatouros, Jiekun Yang +24 more

Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical Trials

Journal of Pain and Symptom Management(2024)10.1016/j.jpainsymman.2024.12.021

N/A

0.208DataRank · unranked

3 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Mehta Kircher, Shaji Kumar, Ingrid A. Mayer +10 more

Single-cell RNA-sequencing and -imaging of melanoma ecosystems reveals sources of resistance to immune checkpoint blockade.

Journal of Clinical Oncology(2018)10.1200/jco.2018.36.15_suppl.3074

N/A

0.208DataRank · unranked

1 citations

Livnat Jerby-Arnon, Asaf Rotem, Parin Shah, David Liu, Gao Zhang +13 more

Neighborhood socioeconomic disadvantage, tobacco use, and cessation indicators among adults with cancer in the United States: Results from 10 ECOG-ACRIN trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6514

N/A

0.189DataRank · unranked

2 citations

Ju‐Whei Lee, Ilana F. Gareen, Sheetal Kircher, B. Herman, Joanna M. Streck +14 more

First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-4141

N/A

0.108DataRank · unranked

1 citations

Dana B. Cardin, F. Stephen Hodi, Patricia LoRusso, Taha Merghoub, Roberta Zappasodi +8 more

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22078

N/A

0.104DataRank · unranked

1 citations

Yue Zheng, Sandra J. Lee, F. Stephen Hodi, UMA RAO, Gary I. Cohen +4 more

Soluble PD-L1 as a marker of progressive disease on nivolumab in kidney cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.746

N/A

0.104DataRank · unranked

1 citations

Petra Ross‐Macdonald, Sachet A. Shukla, David A. Braun, Linan Song, Eliseo Veras +7 more

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.60

N/A

0.104DataRank · unranked

1 citations

Sandra J. Lee, Ni Kang, F. Stephen Hodi, Uma N. M. Rao, Gary I. Cohen +5 more

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.700

N/A

0.104DataRank · unranked

1 citations

Wubing Zhang, Xiaoqing Wang, Peng Jiang, Nicole Traugh, Ziyi Li +28 more

Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.18.613595

N/A

0.104DataRank · unranked

1 citations

Georgia L. Stirtz, Asaf Tal, Ajit J. Nirmal, N. Besson, Stephanie M. Jones +34 more

Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102984

N/A

0DataRank · unranked

2 citations

Wei Wang, F. Stephen Hodi, Le Min, Wei Lin

88 Evidence of enhanced immune activation within the tumor microenvironment and the circulation of female patients with high-risk melanoma compared to males

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.088

N/A

0DataRank · unranked

1 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +9 more

Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor–Induced Hepatitis

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7013

N/A

0DataRank · unranked

11 citations

Danny Wong, Jordan Sack, Alexander S. Vogel, F. Stephen Hodi, Lawrence Fong +4 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Data from A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6531336.v1

Top 100%

0DataRank

Top 100%0 citations

Anita Giobbie‐Hurder, Ana Lako, Emily M. Thrash, Ryan Brennick, Katrina Kao +29 more

Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

(2023)10.1158/2326-6066.22537789

N/A

0DataRank · unranked

0 citations

Donald P. Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada +18 more

A Lasso Cox score consisting of CTLA4+ regulatory T cells (Treg), monocytic myeloid derived suppressor cells (M-MDSC), and CXCR3+ CD8+ T cells: Association with adjuvant ipilimumab (ipi) survival outcomes in patients (pts) with high-risk melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e21557

N/A

0DataRank · unranked

0 citations

Timothy I. Shaw, Sandra J. Lee, F. Stephen Hodi, Patrick Hwu, Dung‐Tsa Chen +7 more

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

Advanced Science(2024)10.1002/advs.202400921

N/A

0DataRank · unranked

8 citations

Shun Zhang, Amy X. Zhong, Liling Xu, Mark F. Coughlin, Georgios Pavlou +9 more

87 Enhanced immunogenicity within the tumor microenvironment and the circulation of high-risk melanoma patients with unknown primary compared to those whose primary melanoma is known

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-sitc2021.087

N/A

0DataRank · unranked

0 citations

Aik Choon Tan, Issam El Naqa, Sandra Lee, F. Stephen Hodi, Lisa H. Butterfield +8 more

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e22090

N/A

0DataRank · unranked

0 citations

Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, UMA RAO, Vernon K. Sondak +2 more

CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

Cell(2025)10.1016/j.cell.2025.09.021

N/A

0DataRank · unranked

11 citations

Georgia L. Stirtz, Asaf Tal, Ajit J. Nirmal, Kathleen L. Pfaff, Michael P. Manos +39 more

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress

Cancer Letters(2025)10.1016/j.canlet.2025.217984

N/A

0DataRank · unranked

3 citations

Marc Machaalani, Laxminarayan Rawat, Johannes Wedel, Saba Tabasum, Yuzuru Sasamoto +14 more

F. Stephen Hodi

Indexed papers

Top data-sharing exemplar

Papers